Current Report · Items 8.01, 9.01 · 8-K
BioCardia, Inc.
BCDANASDAQEQUITYCurrent
Other Events
Item 8.01 Other Events. On September 23, 2026, BioCardia, Inc. issued a press release that confirms timing and provides an update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin Submission. A copy of the press release is attached hereto as Exhibit 99.1 to this current report on Form 8-K.…
Filed Sep 23, 2026Accepted Sep 23, 2026, 9:15 AM EDTCIK 925741Accession 0001437749-26-031011
Company context
Current securities
Historical securities (1)
Registered securities in this filing
BIOCARDIA, INC. · 8-K · Filed 2026-09-23
As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.
Common Stock
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Filing context
Context: d20268K
Dimensions: Not supplied
Accession 000143774926031011 · 1 registered-security cover member
Read the exact SEC filing ↗Disclosure sections
Items 8.01, 9.01Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events.
On September 23, 2026, BioCardia, Inc. issued a press release that confirms timing and provides an update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin Submission.
A copy of the press release is attached hereto as Exhibit 99.1 to this current report on Form 8-K.
The information furnished pursuant to this Item 8.01, including Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that section, nor shall it be deemed to be incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly set forth by specific reference in such filing.